Advanced search
Publication Cover
Scandinavian Journal of Rheumatology Volume 35, 2006 - Issue 4
Submit an article Journal homepage
64
Views
14
CrossRef citations to date
0
Altmetric
LETTERS

Demyelinating disease and cutaneous lymphocitic vasculitis after etanercept therapy in a patient with rheumatoid arthritis

V. M. Martínez‐Taboada Divisions of RheumatologyCorrespondence[email protected]
,
J. F. Val‐Bernal Pathology
,
L. C. Pesquera Radiodiagnostic Unit, Clínica Mompía, SantanderSpain
,
N. E. Fernández‐Llanio Divisions of Rheumatology
,
J. M. P. Esteban Neurology, Hospital Universitario ‘Marqués de Valdecilla’, Facultad de Medicina, Universidad de Cantabria
,
R. Blanco Divisions of Rheumatology
,
P. Alonso‐Bartolome Divisions of Rheumatology
,
C. Gonzalez‐Vela Pathology
&
V. Rodríguez‐Valverde Divisions of Rheumatology
 show all
Pages 322-323 | Received 14 Jun 2005, Accepted 23 Dec 2005, Published online: 12 Jul 2009

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

SATVEER K. Mahil, THOMASIN C. Andrews, CHARLOTTE Brierley, JONATHAN N. Barker & CATHERINE H. Smith. (2013) Demyelination during tumour necrosis factor antagonist therapy for psoriasis: a case report and review of the literature. Journal of Dermatological Treatment 24:1, pages 38-49.
Read now
Raj Patel, John M Cafardi, Nital Patel, Naveed Sami & Jennifer A Cafardi. (2011) Tumor necrosis factor biologics beyond psoriasis in dermatology. Expert Opinion on Biological Therapy 11:10, pages 1341-1359.
Read now
T Cobo-Ibáñez & E Martín-Mola. (2007) Etanercept: long-term clinical experience in rheumatoid arthritis and other arthritis. Expert Opinion on Pharmacotherapy 8:9, pages 1373-1397.
Read now
R. E. Clemente. (2007) Demyelinating disease and cutaneous lymphocitic vasculitis after etanercept therapy in a patient with rheumatoid arthritis. Scandinavian Journal of Rheumatology 36:3, pages 244-245.
Read now

Articles from other publishers (10)

Tumay Ak, Rana Berru Durmus & Muhammed Onel. (2022) Cutaneous vasculitis associated with molecular tergeted therapies: systematic review of the literature. Clinical Rheumatology 42:2, pages 339-357.
Crossref
Camila da Silva Cendon Duran, Adriane Souza da Paz & Mittermayer Barreto Santiago. (2022) Vasculitis induced by biological agents used in rheumatology practice: A systematic review. Archives of Rheumatology 37:2, pages 300-310.
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs 158 170 .
Brian A. Baldo. (2015) Chimeric Fusion Proteins Used for Therapy: Indications, Mechanisms, and Safety. Drug Safety 38:5, pages 455-479.
Crossref
Andrew J SolomonRebecca I SpainMichael C KruerDennis Bourdette. (2011) Inflammatory neurological disease in patients treated with tumor necrosis factor alpha inhibitors. Multiple Sclerosis Journal 17:12, pages 1472-1487.
Crossref
María Cruz Fernández-Espartero, Beatriz Pérez-Zafrilla, Antonio Naranjo, Carmen Esteban, Ana M. Ortiz, Juan J. Gómez-Reino & Loreto Carmona. (2011) Demyelinating Disease in Patients Treated with TNF Antagonists in Rheumatology: Data from BIOBADASER, a Pharmacovigilance Database, and a Systematic Review. Seminars in Arthritis and Rheumatism 41:3, pages 524-533.
Crossref
Andrea T. Borchers, Naama Leibushor, Gurtej S. Cheema, Stanley M. Naguwa & M. Eric Gershwin. (2011) Immune-mediated adverse effects of biologicals used in the treatment of rheumatic diseases. Journal of Autoimmunity 37:4, pages 273-288.
Crossref
F.A. Goumas, F. Braun, D.C. Broering & M. Behrend. 2009. 589 618 .
Manuel Ramos-Casals, Pilar Brito-Zerón, Maria-Jose Cuadrado & Munther A. Khamashta. (2009) Vasculitis induced by tumor necrosis factor-targeted therapies. Current Rheumatology Reports 10:6, pages 442-448.
Crossref
Manuel Ramos-Casals, Pilar Brito-Zerón, Sandra Muñoz, Natalia Soria, Diana Galiana, Laura Bertolaccini, Maria-Jose Cuadrado & Munther A. Khamashta. (2007) Autoimmune Diseases Induced by TNF-Targeted Therapies. Medicine 86:4, pages 242-251.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.